For a Legal Perspective on today's much-anticipated U.S. Supreme Court "Myriad" decision that naturally occuring substances are not patentable, we turned to IP attorneys writing on JD Supra...more
- AMP v Myriad Biotechnology DNA Healthcare Human Genes Legal Perspectives Myriad Patents SCOTUS
The following chart reflects a stratified list of recommendations that university personnel should consider in view of the new U.S. patent system, i.e., the America Invents Act (AIA), which is intended to align the current...more
- America Invents Act Derivation Proceeding First-to-File Inter Partes Review Proceedings Micro Entity Status Patents Prior Art USPTO
On November 30, 2012, the Supreme Court granted certiorari – in what portends to be one of the most impactful decisions in patent law history – to end the “gene patenting” debate, an issue that lower courts have measured over...more
- Bilski Biotechnology DNA Human Genes Myriad Patents SCOTUS
JD Supra gets your content noticed, increases your visibility and makes your marketing efforts hassle free...
Learn More or Schedule a demo